All Transactions - Bryan, Garnier & Co

Our transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to leading European cybersecurity company EclecticIQ on its follow-on placement with the European Investment Bank, securing the total funding to the firm of EUR 35 million over the last 12 months

Bryan, Garnier & Co acts as Sole Financial Advisor to Parquest Capital on its minority investment in Advens

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Kea & Partners on the minority investment by Crédit Mutuel Equity and the debt operations conducted by LCL and Banque Palatine

Bryan, Garnier & Co acts as Sole Financial Advisor to Orfite and BNP Paribas Développement on the sale of Groupe GSCM to Equistone Partners Europe and BNP Paribas Développement reinvestment

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI)

Bryan, Garnier & Co acts as Sole Financial Advisor to TVH Consulting and its shareholders on its secondary LBO with 21 Invest

Bryan, Garnier & Co acts as Sole Financial Advisor to Qred on its Private Placement pursued by Nordic Capital

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista on its acquisition of Goverlan, Inc and its financing by Blackrock

Bryan, Garnier & Co acts as Sole Financial Advisor to Arturia on its capital and debt reorganization led by its management team and EMZ Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to the French cloud operator Oceanet Technology and its shareholders on its sale to Celeste, the InfraVia-backed French telecom operator

Bryan, Garnier & Co acts as Joint Bookrunner on Mister Spex’s EUR 326 million Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Strategic Advisor, Sole Global Coordinator and Joint Bookrunner to HDF Energy on its EUR 132.2 million Initial Public Offering including Strategic Investments from Rubis and Teréga

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Heidelberg Pharma’s EUR 20 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Abivax’s EUR 85 million Follow-on Offering & Convertible Bonds Issuance

Bryan, Garnier & Co acts as Joint Bookrunner on Swedish Stirling’s SEK 225 million Follow-on Offering

Bryan, Garnier & Co advises Halma on its acquisition of PeriGen

Bryan, Garnier & Co acts as Joint Bookrunner to Valneva on its USD 108 million Nasdaq Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Laboratoires Majorelle on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero

Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering

GenSight_2021_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering

Azelio_website_tombstone_march2021

Bryan, Garnier & Co acts as Sole Financial Advisor to Medisys on its merger with Cityzen

Medisys_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Metsys on its growth financing led by European Digital Group

Metsys_tombstone_2

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Basilea Pharmaceutica on its CHF 46 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Ginolis Ltd on the sale of the company to BICO AB

Bryan, Garnier & Co acts as Sole Financial Advisor to the Sellers of Radon Creative to Valtech

Radon_Creative_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to MedinCell on its EUR 30 million Follow-on Offering

Medincell_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to TA Associates on its majority growth investment in DL Software

DL_Software_tombstone

Bryan, Garnier & Co helps Zealand Pharma raise DKK 749 million from the global capital markets via an accelerated bookbuild

Zealand_Pharma_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Martha Flora on the sale of minority stake to DomusVi

Martha_flora_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of BioBag in the sale of the company to Novamont

BioBag_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Lifco on its acquisition of ContacEZ

Lifco_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the founders and shareholders of TagPay on Long Arc Capital’s investment

TagPay_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor and Placement Agent to asgoodasnew, the German circular economy pioneer, on its EUR 18 million Series C private placement

asgoodasnew_website_tombstone_2

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering

Nicox_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Calliditas Therapeutics on its acquisition of Genkyotex for €88 million

Calliditas_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to leading European cybersecurity company EclecticIQ on its EUR 20 million Series C capital raise led by Ace Management (a Tikehau Capital company)

EclecticlQ_website_tombstone_3

Bryan, Garnier & Co acts as Financial Advisor in Apax Partners’ investment in Diapason

Diapason_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Specim on the sale of the company to Konica Minolta

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Proparco on its EUR 23 million Secondary Offering of Voltalia shares

Voltalia_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to IT services group Artemys and its founders on a minority LBO operation with Andera Partners

Artemys_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Amplexor International on the disposal of its France-based digital document engineering business unit, Amplexor Business Services, to Hivest Capital Partners

Amplexor_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering

Abivax_website_tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering

Tombstone_gensight

Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies

McPhy_website_tombstone_4

Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud

Innothera_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu

tombstone_sword_argos